GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

In addition, in the coming years, oral GLP-1 receptor agonists and injectable formulations that require less-frequent dosing—monthly perhaps—may become available, which could change considerations ...

Learn about GLP-1 medications, their benefits, risks and who should (or shouldn’t) consider using them. Design elements: Getty Images. Collage: Cassie Basford. Reviewed by Dietitian Jessica Ball ...

Demand for Ozempic and other GLP-1 receptor agonist medications has soared recently due to their effectiveness for weight loss. In fact, semaglutide topped a list of drug spending in the United ...

Here is a list of commonly prescribed GLP-1 medications: GLP-1 medications offer a range of potential health benefits, specifically for those with type 2 diabetes or those looking to lose weight.

Plus, we note that GLP-1 drugs can increase ... removing Lilly’s obesity drug… Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list White House should declare ...

There's no doubt that Roche is playing catchup in the category, one of a lengthening list of pharma companies ... a once-daily formulation of its oral GLP-1 drug danuglipron as its preferred ...